Fig. 9 | Scientific Reports

Fig. 9

From: Network pharmacology-based investigation of the pharmacological mechanisms of diosgenin in nonalcoholic steatohepatitis

Fig. 9

Activation of the PI3K-Akt pathway by diosgenin activates lipid metabolism in hepatocytes. (A) Western blotting was used to detect PI3K, p-AKT, and AKT protein expression. (C) Western blotting was used to detect the protein expression of CPT1α, an indicator of fatty acid oxidation. (E) protein expression of other fatty acid metabolism-related indicators determined by Western blotting. (B, D, F) the data shown in the bar graphs indicate the mean ± standard deviation of three independent experiments. * indicates P < 0.05, ** indicates P < 0.01.

Back to article page